ARCHIVES

In Brief: Increased Output Can Hold Down High Let Cost, Kligerman says; No More Groups On The Block

This article is from The Cancer Letter archive.

Vol. 03 No. 11 | March 18, 1977

Download PDF Visit The Full Archive

Related Articles

Isis 3521 Gets Fast-track Status For FDA Review.

December 1, 2000

Includes 8-page April 2002 Business & Regulatory Report.

May 3, 2002

Cancer Meetings Listed For Next Three Months

September 20, 1996

Clara Bloomfield To Receive ASCO’s Karnofsky Award. V. Craig Jordan Named Lombardi Scientific Director

April 17, 2009

Movement To Resolve Patient Care Reimbursement Problems Gains Momentum; NCI Report Adds Fuel

March 17, 1989

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002